✦ LIBER ✦

Phase II study of liposomal cisplatin (Lipoplatin™) plus gemcitabine versus cisplatin plus gemcitabine as first line treatment in inoperable (stage IIIB/IV) non-small cell lung cancer

✍ Scribed by Mylonakis, N.; Athanasiou, A.; Ziras, N.; Angel, J.; Rapti, A.; Lampaki, S.; Politis, N.; Karanikas, C.; Kosmas, C.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Gemcitabine plus conventional-dose epiru

✍ Hsu, Chiun; Kuo, Sung-Hsin; Hu, Fu-Chang; Cheng, Ann-Lii; Shih, Jin-Yuan; Yu, Ch 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 506 KB

O-220 Gemcitabine plus cisplatin versus

✍ Zatloukal, Petr; Petruzelka, Lubos; Zemanova, Milada; Kolek, Vitezslav; Skrickov 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 174 KB

Gemcitabine plus cisplatin vs. gemcitabi

✍ Zatloukal, Petr; Petruželka, Luboš; Zemanová, Milada; Kolek, Vı́tězslav; Skřičko 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 223 KB

Randomized, multicenter, phase II study

✍ Mazzanti, Paola; Massacesi, Cristian; Rocchi, Marco B.L.; Mattioli, Rodolfo; Lip 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 216 KB

Gemcitabine plus carboplatin (Gcarb) ver

✍ A.C. Grigorescu; I.N. Draghici; N. Gutulescu; E. Corlan 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 183 KB

A randomized phase II study of recombina

✍ Xin Zhao, Kai Mei, Xiaohong Cai, Jing Chen, Jingrui Yu, Chengya Zhou, Qiu Li 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 136 KB